Headed up by a management team and personnel who pioneered use of optoacoustic technology for noninvasively and directly measuring tissue oxygen saturation employing patented optoacoustic technology, Noninvasix, Inc. - an Alumni of JLab Houston, TX - has developed an elegant solution for the safe, accurate and non-invasive monitoring of infant welfare during labor and delivery. A major cause of death and permanent disability in newborns is inadequate oxygen supply. Brain hypoxia, characterized by restricted blood flow to the brain, accounts for 23% of all neonatal deaths worldwide making the development of an accurate and precise patient monitoring system a top maternal-fetal health priority Employing Noninvasix's enhanced brain monitoring system, doctors can intervene before brain function is permanently compromised. The firm's's novel solution utilizes opto-acoustic monitoring of cerebral venous oxygenation to accurately measure the amount of oxygen a baby is receiving in real time.
